Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "Financial-Leverage-Ratio" stands at 2.04 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Financial Leverage Ratio" stands at 2.04. This represents a decrease of -0.92 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.53 percent compared to the value the year prior.
The 1 year change in percent is -2.53.
The 3 year change in percent is -10.05.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Financial Leverage Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Financial Leverage Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Financial Leverage Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Financial Leverage Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Financial Leverage Ratio | 280,205,508,085.11 |